$180,000 of GUARDANT HEALTH lobbying was just disclosed, from Q2 of 2026, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"precision diagnostics and preventive screening innovation precision diagnostics, cancer care, and preventive screening innovation"

You can find more data on corporate lobbying on Quiver Quantitative.

GH Insider Trading Activity

GH insiders have traded $GH stock on the open market 63 times in the past 6 months. Of those trades, 1 have been purchases and 62 have been sales.

Here’s a breakdown of recent trading of $GH stock by insiders over the last 6 months:

• AMIRALI TALASAZ (Co-Chief Executive Officer) has made 0 purchases and 19 sales selling 520,000 shares for an estimated $67,405,344.
• HELMY ELTOUKHY (Co-Chief Executive Officer) has made 0 purchases and 7 sales selling 100,000 shares for an estimated $12,629,968.
• KUMUD KALIA (Chief Information Officer) has made 1 purchase buying 600 shares for an estimated $78,456 and 6 sales selling 49,618 shares for an estimated $5,067,010.
• JOHN G. SAIA (Chief Legal Officer) has made 0 purchases and 5 sales selling 30,000 shares for an estimated $3,381,064.
• CHRIS FREEMAN (Chief Commercial Officer) sold 24,406 shares for an estimated $2,896,360
• TERILYN J. MONROE (Chief People Officer) has made 0 purchases and 4 sales selling 12,403 shares for an estimated $1,333,051.
• MEGHAN V. JOYCE has made 0 purchases and 4 sales selling 10,000 shares for an estimated $1,269,808.
• STEVE E. KROGNES sold 9,294 shares for an estimated $1,231,521
• IAN T CLARK sold 6,876 shares for an estimated $735,048
• MICHAEL BRIAN BELL (Chief Financial Officer) has made 0 purchases and 2 sales selling 5,000 shares for an estimated $518,351.
• MEDINA MANUEL HIDALGO has made 0 purchases and 5 sales selling 3,550 shares for an estimated $382,920.
• MUSA TARIQ has made 0 purchases and 6 sales selling 2,763 shares for an estimated $341,563.
• MYRTLE S POTTER sold 1,556 shares for an estimated $204,084

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

GH Hedge Fund Activity

We have seen 235 institutional investors add shares of GH stock to their portfolio, and 207 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• TWO SIGMA INVESTMENTS, LP added 2,057,628 shares (+94.7%) to their portfolio in Q1 2026, for an estimated $190,063,098
• PIER 88 INVESTMENT PARTNERS LLC added 2,050,380 shares (+30064.2%) to their portfolio in Q1 2026, for an estimated $189,393,600
• GOLDMAN SACHS GROUP INC added 1,808,266 shares (+68.8%) to their portfolio in Q1 2026, for an estimated $167,029,530
• FMR LLC added 1,719,648 shares (+71.8%) to their portfolio in Q1 2026, for an estimated $158,843,885
• PRICE T ROWE ASSOCIATES INC /MD/ added 1,387,611 shares (+24.6%) to their portfolio in Q1 2026, for an estimated $128,173,628
• JENNISON ASSOCIATES LLC removed 966,559 shares (-82.6%) from their portfolio in Q1 2026, for an estimated $89,281,054
• WESTFIELD CAPITAL MANAGEMENT CO LP added 823,349 shares (+152.7%) to their portfolio in Q1 2026, for an estimated $76,052,747

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

GH Analyst Ratings

Wall Street analysts have issued reports on $GH in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• BTIG issued a "Buy" rating on 02/20/2026

To track analyst ratings and price targets for GH, check out Quiver Quantitative's $GH forecast page.

GH Price Targets

Multiple analysts have issued price targets for $GH recently. We have seen 21 analysts offer price targets for $GH in the last 6 months, with a median target of $160.0.

Here are some recent targets:

• Shannon O'Callaghan from Morgan Stanley set a target price of $175.0 on 07/09/2026
• Patrick Donnelly from Citigroup set a target price of $215.0 on 07/08/2026
• Michael Ryskin from B of A Securities set a target price of $190.0 on 07/06/2026
• Vijay Kumar from Evercore ISI Group set a target price of $200.0 on 07/06/2026
• Eve Burstein from Bernstein set a target price of $200.0 on 07/02/2026
• Mark Massaro from BTIG set a target price of $190.0 on 07/01/2026
• Subbu Nambi from Guggenheim set a target price of $160.0 on 06/29/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Read full article here »